Harrow Q3 2026: Record Revenue but EBITDA Guidance Slashed

What happened

Harrow reported record third quarter 2026 revenue of $99.3 million, up 41% sequentially and 39% year over year, with branded products contributing 84% of total revenue and growing 62% year over year. The company returned to GAAP profitability with net income of $9.8 million, though this included a $5.0 million litigation settlement gain, and adjusted EBITDA recovered to $21.2 million from negative $1.2 million in the second quarter. However, management sharply reduced full-year 2026 adjusted EBITDA guidance to 'more than $40 million' from the previous range of $80 million to $100 million, a cut of over 50%, even as revenue guidance was reaffirmed. While the cash position of $75.3 million offers some liquidity, the company's balance sheet remains highly leveraged with significant interest obligations, as previously highlighted. The mixed results—strong top-line growth but weaker-than-expected profitability—suggest that operational improvements are not yet translating into durable free cash flow.

Implication

The record revenue and branding momentum are encouraging, but the slashed EBITDA guidance indicates that cost pressures or investments are eating into margins more than anticipated. The positive net income was flattered by a one-time litigation gain, and core operating performance remains modest relative to the company's debt load. With net debt/EBITDA still elevated and interest coverage historically below 1x, even improved EBITDA may not be sufficient to service debt comfortably and fund growth. The company's ability to reach the new full-year EBITDA guidance hinges on a sharp fourth-quarter acceleration, which adds execution risk. Until Harrow demonstrates sustained free cash flow and meaningful deleveraging, the stock's valuation appears to embed more optimism than the fundamentals support, maintaining a cautious or sell bias.

Thesis delta

The prior 'POTENTIAL SELL' judgment was based on a stretched balance sheet and unproven profitability. While Q3 2026 shows accelerating revenue and a return to positive net income and adjusted EBITDA, the drastic reduction in full-year EBITDA guidance from $80-100M to over $40M undercuts the operating-leverage narrative. This development suggests that the company's cost structure is less scalable than hoped, reinforcing the view that the risk/reward remains unfavorable.